NC Veterans Art Show

 November 9 through November 12, 2023- The Joel Fund and Heart2Hand Veteran artist Lt. Colonel (retired) Bernardine Donato will host the second annual four-day art exhibit at the Tobacco Wood Brewing Company (TWBC) Durham location.

This family-friendly art show will contain original pieces created by North Carolina Veterans of the United States Armed Forces. For many veterans, creative expression is one conduit for processing emotions and personal narratives when sometimes words fail. A Closing Reception will be on Sunday, November 12, from 3-5 PM at TWBC.

Brooke Dickhart started The Joel Fund (TJF) in 2016 in honor of her father who was a Navy SEAL. The Joel Fund’s mission is to reconnect veterans to life at home. They use the power of community to engage, educate and encourage veterans and their families. TJF’s Operation ART Program offers low-cost art classes for veterans and their families. Operation ART program veteran students will also showcase their work created in art classes taken at the Joel Fund.

Heart2Hand artist Lt. Col (retired) Bernardine Donato, Navy and Air Force veteran served 24 years in the military, including two deployments to Operation Desert Storm. She has won multiple awards in local North Carolina artists competitions and has had artwork displayed in the Virginia War Memorial Gallery and Australian Veterans Art Museum Exhibit at the 2018 Invictus Games.

Tobacco Wood Brewing Company is headed by Mara Shelton and is the first female veteran-owned brewery in North Carolina. Known for its award-winning local beer, community events, veteran focus, and support of the arts, TWBC is a perfect place to showcase North Carolina Veteran Artists.

Join us this Veterans Day weekend at Tobacco Woods Brewing Company at 2500 Meridian Parkway, Durham, NC 27713, to appreciate original military veterans’ artwork while enjoying food, beer, or soft drinks.

The Joel Fund
Isabella Brezenski



  • Art

Veterans For Trump Endorsement of Rep Alex Mooney for West Virginia Senate 2024

 Veterans for Trump aka Veterans for America First has endorsed Rep. Alex Mooney for West Virginia Senate to challenge Joe Manchin.

“Alex Mooney is a supporter of our veterans and law enforcement he has an outstanding conservative voting record which demonstrates he is the best candidate for the seat,” said Stan Fitzgerald President Veterans for Trump.

“Representative Alex Mooney has done an outstanding job as Congressman in West Virginia. In fact, he recently opposed the horrendous Biden Administration’s ‘non-Infrastructure’ plan, and he opposed the January 6th Committee. Alex has been strong on crime, borders, our great military, and a champion of our veterans. He will always protect our Second Amendment, and of particular importance is the fact that Alex fights for energy and beautiful clean coal–and he will never stop.” Said President Donald J. Trump Quote Source

Veterans For Trump aka VFAF
Stan Fitzgerald



  • Political Issues

U.S. Veterans’ Health Administration (VHA) Provides Coverage of LEQEMBI (lecanemab-Irmb) Two Months After LEQEMBI’s FDA Accelerated Approval for Veterans Living with Early Stages of Alzheimer’s Disease

Eisai Co., Ltd. announced today that the U.S. Veterans’ Health Administration (VHA) is providing coverage of LEQEMBI (lecanemab-irmb) to veterans living with early stages of Alzheimer’s disease (AD). VHA healthcare professionals meeting the criteria set forth by the VHA can prescribe LEQEMBI to veterans who fit the VHA’s criteria and the U.S. Food and Drug Administration’s (FDA) current label. The VHA’s careful consideration and timely action to make LEQEMBI available approximately two months after the FDA approved LEQEMBI under the accelerated approval pathway shows its continued commitment to veterans living with AD.

If approved under the traditional pathway, the FDA will update the label for LEQEMBI, which will include new data that has been evaluated by the FDA. Eisai looks forward to sharing additional high-quality data as it becomes available and to continuing discussions with the VHA as the company prepares for the FDA’s potential conversion of LEQEMBI’s accelerated approval to a traditional approval. Eisai is proud of and humbled by the opportunity to support U.S. veterans as we strive to fulfill our human health care (hhc) mission.

LEQEMBI is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibrils*) and insoluble forms of amyloid beta (Aβ), LEQEMBI was approved in the U.S. under the Accelerated approval Pathway for the treatment of AD on January 6, 2023, and was launched in the U.S on January 18, 2023. Treatment with LEQEMBI should only be initiated in patients with mild cognitive impairment or mild dementia stage of disease and confirmed presence of Aβ pathology.

The Accelerated approval was based on Phase 2 data that demonstrated that LEQEMBI reduced the accumulation of Aβ plaque in the brain, a defining feature of AD, and its continued approval may be contingent upon verification of LEQEMBI’s clinical benefit in a confirmatory trial. The FDA has determined that the results of Clarity AD will serve as the confirmatory study to verify the clinical benefit of LEQEMBI.

On the same day that LEQEMBI received its Accelerated approval, Eisai submitted the supplemental Biologics License Application (sBLA) to the FDA for approval under the Traditional pathway. The sBLA was accepted by the FDA on March 3, 2023 and granted Priority Review with a Prescription Drug User Fee Act (PDUFA) date of July 6, 2023. The sBLA is based on the findings from Eisai’s recently published large, global confirmatory Phase 3 clinical trial, Clarity AD. LEQEMBI met the primary endpoint and all key secondary endpoints with highly statistically significant results. In November 2022, results of the Clarity AD study were presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference and simultaneously published in the peer-reviewed medical journal, The New England Journal of Medicine.

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.

*Protofibrils are large Aβ aggregated soluble species of 75-500 Kd.1

To learn more, visit,

Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.

Eisai Inc (U.S.)
Libby Holman

Eisai Europe, Ltd.
(UK, Europe, Australia, New Zealand and Russia)
EMEA Communications Department

Topic: Press release summary

Veteran’s Son with TBI Featured in SHIFT Magazine After Writing Children’s Book

 Josh Goblowsky recently released his new children’s book, “Josh’s World.” It’s about a baby dragon with disabilities and how he sees the world. Josh was severely injured at the age of 3 in an hit-and-run involving two semi trucks.

The massive Traumatic Brain Injury effected every area of his life; cognitive, emotional, and physical. He has been through two thousand appointments in the sixteen years since the injury. His cognitive abilities have suffered the most severe part of the injury.

His father, Mark Goblowsky, was an Air Force veteran and took it upon himself to make sure that Josh’s life was as normal as possible. Now, in his 20s, Josh still has the emotional maturity of a 10-year-old, but an indomitable spirit. He wanted to write a book so that other children and young adults with disabilities could relate to his situation.

They brought in illustrator, Justin William Gordon for the drawings. Josh created a list of chapter ideas and story content with Jennifer Perea, who helped get his thoughts down on paper. Mark handled the publishing duties.

Joshua is donating 100% of the proceeds to the Sunshine Foundation which helps chronically ill children fulfill their dreams.

As of 2022, the market size of the Children’s Book Publishing industry is $2.6 billion, an increase of 2.22% from 2021. (IBIS world website, 2022)

Josh’s book has been featured in SHIFT Magazine’s March/April issue with a full review and recap of Josh’s story.

“I’m really proud of Josh for doing this, it’s a great way for him to connect with other young people around the world and share his story which in many ways are like Josh’s story.” – Mark Goblowsky

To purchase a copy of “Josh’s World,” go to Amazon:

Shift Magazine

Robert Garcia




  • Arts & Entertainment
  • Books
  • Children & Youth
  • Disability
  • Publishing
  • Society

Canada – Ministers of Veterans Affairs and National Defence commemorate Battle of Vimy Ridge

Ottawa, ON – In the early stages of the First World War, Germany captured Vimy Ridge in northern France and turned it into a strong defensive position.

Ottawa, ON – In the early stages of the First World War, Germany captured Vimy Ridge in northern France and turned it into a strong defensive position. With its complex system of tunnels and trenches, and a heavy arsenal of machine guns and artillery pieces, the Germans established a nearly impenetrable fortress that the Allies struggled to overtake. Hundreds of thousands of Allied troops would be killed or wounded in unsuccessful assaults on Vimy Ridge in 1914 and 1915.

By the spring of 1917, with Europe having been at war for more than two-and-a-half years and neither side gaining significant ground, a major attack was planned for April in the area around Arras, France.

It would fall to the Canadians to capture Vimy Ridge.

For the first time, all four divisions of the Canadian Corps would fight together as one formation. After spending all winter strengthening the lines, preparing for the assault and training rigorously, the first wave of between 15,000 and 20,000 Canadian soldiers attacked on the morning of 9 April 1917.

In the first phase of the assault, Canadian battalions suffered great numbers of casualties as they came up against fierce and deadly machine gun fire. But by noon of that first day, most of the heavily defended ridge was captured and by 12 April, the Allies commanded the heights overlooking the Douai Plain.

In remembering the Battle of Vimy Ridge, Canadians are encouraged to reflect on the heroism and sacrifices of those who fought so hard to help secure peace in Europe during the First World War.


“Despite the enormous losses suffered by the Canadian Corps in the Battle of Vimy Ridge, they achieved a victory that still today is remembered as one of Canada’s most important military accomplishments. At a time of great instability in the world, we honour the memory of all those who fought and died at Vimy Ridge by pledging to do everything we can to preserve and protect the peace and freedom that their sacrifice helped to give us.”

The Honourable Lawrence MacAulay, Minister of Veterans Affairs and Associate Minister of National Defence

“The bravery and sacrifice demonstrated by Canadian soldiers during the Battle of Vimy Ridge contributed to one of the most significant Allied victories of the First World War. The courageous actions of Canadians in uniform during the great conflicts of the first half of the 20th century, and those of Canadian Armed Forces members in more recent years, have helped ensure that peace and freedom remain pillars of Canadian society. Lest we forget.”

The Honourable Anita Anand, Minister of National Defence

Associated links:


Media Relations

Veterans Affairs Canada


John Embury

Director of Communications

Office of the Minister of Veterans Affairs

Media Relations

Department of National Defence

Phone: 613-904-3333

Daniel Minden

Press Secretary

Office of the Minister of National Defence

Phone: 613-996-3100